Vera Therapeutics SVP Joseph R. Young Exercises Options

What Happened
Joseph R. Young, SVP Finance and Chief Accounting Officer of Vera Therapeutics (VERA), exercised stock options on September 11, 2026. The filing shows he acquired 5,000 shares by exercising options at $3.94 per share (total $19,698). The filing also reports a related exercise/conversion of 5,000 derivative shares with $0 cash proceeds. Both entries are coded as option exercise/conversion (transaction code M).

Key Details

• Transaction date: 2026-09-11; Filing date: 2026-09-14 (filing appears timely).
• Acquired: 5,000 shares @ $3.94 = $19,698 (exercise).
• Disposed/converted: 5,000 derivative shares @ $0 (reported as a disposition/conversion of a derivative).
• Shares owned after the transaction: Not specified in the filing.
• Footnote: F1 — 1/4 of the option vested on March 9, 2022, with 1/48 vesting monthly thereafter (standard multi-year vesting schedule).
• Transaction code: M = Exercise or conversion of derivative securities.

Context
Exercising options is not an open-market purchase or sale; it converts an option into stock. The separate line showing 5,000 derivative shares at $0 often reflects a non-cash conversion or net-settlement mechanism (for example, conversion of restricted shares or withholding), not an open-market sale. These transactions are common for insiders when options vest and do not by themselves indicate the insider’s view of the company’s near-term stock direction.